Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | PD166326 |
Synonyms | |
Therapy Description |
PD166326 is a dual kinase inhibitor of Src and Abl, which can inhibit cellular growth and induce apoptosis (PMID: 12684394, PMID: 15657179, PMID: 19567819). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
PD166326 | BCR-ABL Inhibitor 31 SRC Inhibitor 31 | PD166326 is a dual kinase inhibitor of Src and Abl, which can inhibit cellular growth and induce apoptosis (PMID: 12684394, PMID: 15657179, PMID: 19567819). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|